Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Harvard Bioscience Inc. logo

Harvard Bioscience Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

2.92
 
USD
  
0.03
  
(0.86%)
Optionable: Yes  Market Cap: 120 M  90-day average vol: 116,050

Previous close: 2.895  Open: 2.9  Bid: 2.8  Ask: 3.15
52 week range    
2.75   
   6.20
Last updated: Tuesday 18th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

HBIO Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AcquisitionExpense-438000.0
Amortization of intangibles3 M3 M3 M3 M2 M5 M6 M6 M6 M6 M
Basic EPS from continuing operations0.020.07-0.57-0.06-0.12-0.24-0.2-0.01-0.23
Basic EPS total-0.060.07-0.57-0.13-0.02-0.08-0.24-0.2-0.01-0.23
Basic weighted shares outstanding30 M32 M34 M34 M35 M36 M38 M39 M40 M41 M
BasicDiscontinuousOperations-0.080.030.04
Cost of sales-57 M-59 M-60 M-56 M-38 M-58 M52 M44 M51 M53 M
Depreciation unreconciled3 M3 M3 M3 M2 M5 M6 M6 M6 M6 M
DepreciationAndAmortization3 M3 M3 M3 M2 M5 M6 M6 M6 M6 M
Diluted EPS total-0.060.07-0.57-0.13-0.02-0.08-0.12-0.2-0.01-0.23
Diluted normalized net income/share0.020.07-0.57-0.06-0.12-0.12
Diluted weighted shares outstanding32 M33 M34 M34 M35 M36 M38 M39 M40 M41 M
DilutedDiscontinuousOperations-0.080.030.04
GainOnSaleOfBusiness1 M-228000.0
GainsLossOnDisposalOfDiscontinuedOperations1 M1 M
GeneralAndAdministrativeExpense20 M17 M20 M21 M18 M21 M23 M24 M24 M24 M
Gross operating profit48 M49 M49 M48 M39 M63 M64 M58 M68 M61 M
ImpairmentOfCapitalAssets-810000.0676000.01 M
Income before tax435000.04 M-4 M-3 M-3 M-8 M-5 M-7 M-140000.0-9 M
Income restructuring and M&A2 M1 M788000.0-4000.0-1 M2 M1 M2 M
Income taxes-288000.02 M15 M1 M-605000.0-4 M-815000.0518000.0148000.0337000.0
Interest income-2 M-2 M135000.0-2 M-5 M-5 M-5 M-2 M-3 M
InterestExpenseNonOperating955000.0990000.0854000.0639000.0713000.05 M
InterestIncomeOperating43000.074000.08000.03000.0
MiscOtherSpecialCharges-51000.0-1 M-1 M-179000.0-739000.0-4 M-469000.0-3 M-666000.0302000.0
Net income from total operations723000.02 M-19 M-2 M-865000.0-3 M-5 M-8 M-288000.0-10 M
NetIncomeCommonStockholders723000.02 M-19 M-2 M-865000.0-3 M-5 M-8 M-288000.0-10 M
NetIncomeContinuousOperations723000.02 M-19 M-2 M-865000.0-3 M-5 M-8 M-288000.0-10 M
NetIncomeDiscontinuousOperations-3 M1 M1 M
NetNonOperatingInterestIncomeExpense-955000.0-990000.0-854000.0-639000.0-713000.0-5 M-5 M-5 M-2 M-3 M
NonRecurringOperationExpense-233000.0
Normalized income1 M-5 M
Operating income4 M7 M-925000.0-1 M-635000.0984000.02 M221000.02 M-7 M
Operating income before depreciation (EBITDA)5 M9 M2 M2 M2 M524000.03 M733000.08 M-1 M
OperatingExpense-46 M-43 M-50 M-51 M-40 M-62 M62 M58 M66 M68 M
Other income net51000.01 M1 M-1 M739000.04 M469000.03 M666000.0-302000.0
OtherGandA20 M17 M20 M21 M18 M21 M23 M24 M24 M24 M
OtherImpairmentOfCapitalAssets-100000.0
OtherOperatingExpenses329000.0-43 M-50 M-51 M-40 M-62 M-2 M-5 M-176000.0-237000.0
OtherWriteDown787000.0
RentAndLandingFees18 M17 M20 M21 M18 M21 M
Research & development expense4 M5 M6 M5 M6 M11 M11 M9 M11 M12 M
ResearchExpense4 M5 M6 M5 M6 M11 M11 M9 M11 M12 M
RestructringAndMnAIncome2 M1 M788000.0-4000.0-1 M2 M1 M2 M
Revenue per share3 M3 M3 M3 M2 M5 M6 M6 M6 M6 M
SalariesAndWages-3 M-2 M-3 M-3 M-3 M-3 M-3 M-215000.0349000.0-420000.0
Selling Gen & administrative expense37 M35 M40 M41 M33 M46 M46 M43 M49 M50 M
SellingAndMarketingExpense17 M18 M21 M20 M15 M24 M23 M20 M25 M25 M
SellingExpense17 M18 M21 M20 M15 M24 M23 M
Special income/charges-2 M-217000.0-788000.0-672000.04 M-1 M-2 M-1 M233000.0
Total Income available for interest expense (EBIT)1 M5 M-3 M-2 M-2 M-8 M-5 M-7 M-140000.0-9 M
Total common shares outstanding32 M33 M34 M35 M36 M38 M38 M40 M41 M42 M
Total net income723000.02 M-19 M-2 M-865000.0-3 M-5 M-8 M-288000.0-10 M
Total ordinary shares43 M43 M43 M43 M43 M43 M43 M43 M43 M43 M
Total revenues105 M109 M109 M105 M77 M121 M116 M102 M119 M113 M
TotalExpenses-104 M-102 M-110 M-108 M-78 M-120 M114 M102 M117 M120 M
TotalRevenue105 M109 M109 M105 M77 M121 M116 M102 M119 M113 M
WriteDown484000.0-4 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University